Delta aminolevulinate dehydratase (ALA-D) activity in human and experimental diabetes mellitus

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 3-4, 1999, Pages 479-488

  Fernandez Cuartero B ^a   Rebollar, J L ^a   Batlle, A ^a   Enriquez De Salamanca, R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Aminolevulinate dehydratase; diabetes mellitus; Glycosylated hemoglobin; Haem pathway; Porphyrin metabolism

Indexed keywords

FERRITIN; GLYCOSYLATED HEMOGLOBIN; HEME; INSULIN; PORPHOBILINOGEN SYNTHASE; SULFONYLUREA DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ERYTHROCYTE; HEMOSIDEROSIS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PORPHYRIN METABOLISM; RAT; STREPTOZOCIN DIABETES; ZINC BLOOD LEVEL;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANIMALS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PORPHOBILINOGEN SYNTHASE; RATS; RATS, WISTAR; ZINC;

ANIMALIA; RATTUS NORVEGICUS;

EID: 18244425280     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00145-9     Document Type: Article

References (61)

1. Sterling K., Silver M., Riketts H.T. Development of porphyria in diabetes mellitus. Arch. Intern. Med. 84:1949;965-975.
2. Burnham T.K., Fossnaugh R.P. Porphyria, diabetes and their relations. Arch. Dermatol. 83:1961;717-722.
3. Goerz G., Korda S. Porphyria cutanea tarda and diabetes mellitus. Z. Haut. 52:1977;1165-1174.
4. Franks A.G., Puluni M., Bickers D.R., Rayfield E.J., Harber L.C. Carbohydrate metabolism in porphyria cutanea tarda. Am. J. Med. Sci. 277:1979;163-171.
5. Lenczner J.M., Stella A.M., Parera V.E., Milano R., Spina O., Magnin P.H., Batlle A.M.C. Estudios de la delta aminolevulínico dehidratasa y otros metabolitos del hemo en pacientes porfíricos y diabéticos. Rev. Arg. Derm. 70:1989;143-149.
6. Grossman M.E., Bickers D.R., Poh-Fitzpatrick M.B., Deleo V.A., Harber L.C. Porphyria cutanea tarda clinical features and laboratory findings in 40 patients. Am. J. Med. 67:1979;277-286.
7. Lisi P., Santeusanio F., Lombardi G., Compagnucci P. Carbohydrate metabolism in porphyria cutanea tarda. Dermatologica. 166:1983;287-293.
8. Stein J.A., Tschudy D.P. Acute intermittent porphyria, a clinical and biochemical study of 46 patients. Medicine. 49:1970;1-16.
9. Doss M., Verspohl F. The 'glucose effect' in acute hepatic porphyrias and in experimental porphyria. Klin. Wochenschr. 59:1981;727-735.
10. Bonkovsky H.L., Healey J.F., Lourie A.N., Gerron G.G. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am. J. Gastroenterol. 86:1991;1050-1056.
11. Bonkovsky H.L., Collins A., Doherty J.M., Tschudy D.P. The glucose effect in rat liver: studies of delta-aminolevulinate synthase and tyrosine amino-transferase. Biochim. Biophys. Acta. 320:1973;561-576.
12. Yalouris A.G., Raptis S.A. Effect of diabetes on porphyric attacks. Br. Med. J. 295:1987;1237-1241.
13. Bitar M., Weiner M. Diabetes-induced metabolic alterations in heme synthesis and degradation and various heme-containing enzymes in female rats. Diabetes. 33:1984;37-44.
14. Polo C., Vazquez C., Gerez E., Cabellero F., Batlle A. STZ-induced diabetes in mice and heme pathway enzymes. Effect of allylisopropylacetamide and alfa-tocopherol. Chem. Biochem. Interact. 95:1995;327-334.
15. Kato R., Onoda K., Takanaka A. Species differences in drug metabolism by liver microsomes in alloxan diabetic or fasted animal. I: The activity of drug-metabolizing enzymes and electron transport system. Jpn. J. Pharmacol. 20:1970;546-561.
16. Reinke L.A., Stohs S.J., Rosenberg H. Altered activity of hepatic mixed-function mono-oxygenase enzymes in streptozotocin-induced diabetic rats. Xenobiotica. 8:1978;611-619.
17. Caballero F., Gerez E., Polo C., Mompo O., Vazquez E., Schultz R., Bernabo J., Batlle A. Alteraciones en el camino metabólico del hemo en pacientes diabéticos. Medicina. 55:1995;117-124.
18. Djordjevic V.B. Delta-aminolevulinic acid dehydratase activity in erythrocytes of diabetic patients. Arch. Int. Physiol. Biochim. 91:1985;285-290.
19. Ratnaike S., Blake D., Shevenan P. Enzymic glycation may decrease activity of erythrocytic delta aminolevulinate dehydratase in diabetes mellitus. Clin. Chem. 33:1987;1807-1810.
20. Polo C.F., Cirigliano A., Navone N.M., Garro J.C., Rossetti M.V., Wider E.A. Haem biosynthesis in streptozotocin-induced diabetic mice. Mol. Aspects Med. 11:1990;29.
21. Garro J.C., Polo C.F., Cirigliano A., Rossetti M.V., Wider E.A. Glucose effect on haem metabolism. Mol. Aspects Med. 11:1990;28.
22. Expert Committee On Diabetes Mellitus. OMS. Technical Report Series No. 646. 1980.
23. Batlle A., Magnin P. Porfirinas y porfirias. Aspectos clinicos y bioquimicos. Acta Bioq. Clin. Latinoamer. 2:1988;1-109.
24. Santos J.L., Fontanellas A., Batlle A., Enriquez de Salamanca R. Reference values of 5-aminolevulinate dehydratase and porphobilinogen deaminase in the spanish population from Madrid. Ecotoxicol. Environm. Safe. 39:1998;168-171.
25. Adjarov D.G., Naydenova E.N., Kerimova M.A., Pentieva K.D., Ivanova L.B. Influence of protein calories malnutrition and fasting on the activities of delta-aminolevulinic dehydratase and porphobilinogen deaminase in rats. Exp. Toxicol. Pathol. 46:1994;199-202.
26. Canepa E.T., Llambias E.B.C., Grinstein M. Studies on induction of delta-aminolevulinic acid synthase, ferrochelatase, cytochrome p-450 and cyclic AMP by phenformin. Biochem. Pharmacol. 40:1990;365-372.
27. Jain S.K., Levine S.N., Duett J., Hollier B. Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism. 39:1990;971-975.
28. Berlin A., Schaller K.M. European standardized method for the determination of delta-aminolevulinic acid dehydratase activity in blood. Z. Klin. Chem. Klin. Biochem. 12:1974;389-390.
29. Fujita H., Orii Y., Sano S. Evidence of increased synthesis of delta-aminolevulinic acid dehydratase in experimental lead poisoned rats. Biochim. Biophys. Acta. 678:1981;39-50.
30. L. Sachs, The comparison of independent data samples, in: Applied Statistics. A Handbook of Techniques, Springer-Verlag, New York, 1984, pp. 303-306.
31. M.R. Moore, A. Golberg, Health implications of the hematopoietic effects of lead, in: K.R. Mahaffey (Ed.), Dietary and Environmental Lead. Human Health Effects, Elsevier, Amsterda, 1985, pp. 261-299.
32. Eiseman J.L., Alvares A.P. Alterations induced in haem pathway enzymes and monooxygenases by gold. Mol. Pharmacol. 14:1978;1176-1188.
33. Davis J.R., Avram M.J. A comparison of stimulating effects of cadmium and zinc on normal and lead-inhibited human erythrocytic delta-aminolaevulinic acid dehydratase activity in vitro. Toxicol. Appl. Pharmacol. 44:1978;181-190.
34. McColl K.E.L., Thompson G.G., Moore M.R., Golberg A. Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur. J. Clin. Invest. 10:1980;107-112.
35. Sinclair J.F., Zaitlin L.M., Smith E.L., Howell S.K., Bonkowsky H.L., Sinclair P.R. Induction of delta-aminolevulinate synthase by two to five carbons alcohols in cultured chick-embryo hepatocytes. Biochem. J. 234:1986;405-411.
36. Doss M., Von Tiepermann R., Stutz G., Teschke R. Alcohol induced decrease in uroporphyrinogen decarboxylase activity in rat liver and spleen. Enzyme. 26:1981;24-31.
37. C. Polo, E. Vazquez, E. Gerez, F. Caballero, A. Batlle, Further studies on the non-enzymatic glycosilation of ALA-D, PBG-D and rhodenase, Abstracts International Conference of Porphyrins, Porphyria and Photodynamic therapy, Melbourne, Australia, November 1993.
38. Murakami K., Kondo T., Ohtsuka Y., Fujiwara Y., Shimada M., Kawakami Y. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism. 38:1989;753-758.
39. McLennan S., Heffernan S., Wright L., Rae C., Fisher E., Yue D.K., Turtle J.R. Changes in hepatic glutathione metabolism in diabetes. Diabetes. 40:1991;344-348.
40. Djordjevic V.B., Strahinjic S., Koracevic D., Miljkovic P., Djordjevic V., Pavlovic D., Stefanovic V. Erythrocyte delta-aminolevulinate dehydratase measurements in balkan endemic nephropathy. Kidney Int. 40:1991;93-96.
41. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet. 347:1996;444-445.
42. Ohkuwa T., Sato Y., Naoi M. Hydroxyl radical formation in diabetic rats induced by streptozotozin. Life Sci. 56:1995;1789-1798.
43. Sundaram R.K., Bhaskar A., Vijayalingam S., Viswanathan M., Mohan R., Shanmugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with or without complications. Clin. Sci. 90:1996;255-260.
44. Afonso S.G., Polo C., Enriquez de Salamanca R., Batlle A. Mechanistic studies on uroporphyrin I-induced photoinactivation of some heme enzymes. Int. J. Biochem. Cell Biol. 28:1996;415-420.
45. Bhasker C.R., Burgiel G., Neupert B., Emery-Goodman A., Kuhn L.C., May B.K. The putative iron-responsive element in the human erythroid 5-aminolevulinate synthase mRNA mediates translational control. J. Biol. Chem. 268:1993;12699-12705.
46. Lathrop J.T., Timko M.P. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science. 259:1993;522-525.
47. Chalevelakis C., Lyberatos C., Monopoulos D., Pyrovolakis J., Gardikas C. Erythrocyte delta-aminolaevulinic acid dehydratase, urinary porphyrins and porphyrin precursors in iron deficiency anaemia. Acta Haematol. 57:1977;305-309.
48. Campbell B.C., Meredith P.A., Moore M.R., Goldberg A. Erythrocyte delta-aminolaevulinic acid dehydratase activity and changes in delta-aminolaevulinic acid concentrations in various forms of anaemia. Br. J. Haematol. 40:1978;397-400.
49. McColl K.E.L., Moore M.R., Thompson G.G., Goldberg A. Haem enzymes in peripheral blood cells of patients with iron deficiency anaemia before and after treatment. Br. J. Haematol. 50:1979;584-595.
50. Bonkovsky H.L., Healey J.F., Sinclair P.R., Elder G.H., Sinclair J.F., Shedlofsky S.I. Iron and the liver. Acute effects of iron-loading on hepatic heme synthesis of rats. The role of decreased activity of 5-aminolevulinate dehydrase. J. Clin. Invest. 71:1983;1175-1182.
51. Bonkovsky H.L., Healey J.F., Lincoln B., Bacon B.R., Bishop D.F., Elder G.H. Hepatic heme synthesis in a new model of experimental hemochromatosis: Studies of rats fed finely divided elemental iron. Hepatology. 7:1987;1195-1203.
52. ++ for enzyme activity. J. Biol. Chem. 255:1980;2030-2035.
53. Sandstead H.H. Assessment of zinc nutriture. J. Lab. Clin. Med. 118:1991;299-300.
54. Meftah S., Prasad A.S., Lee D.Y., Brewer J. 5′ nucleotidase [5′NT] as a sensitive indicator of human zinc deficiency. J. Lab. Clin. Med. 118:1991;309-316.
55. Hagglof B., Hallmans G., Holmgren G., Ludvigsson J., Faikmer S. Prospective and retrospective studies of zinc concentrations in serum blood clots, hair and urine in young patients with insulin-dependent diabetes mellitus. Acta Endocrinol. 102:1983;88-95.
56. Kinlaw W.B., Levine A.S., Morley J.E., Silvis S.E., McClain C.J. Abnormal zinc metabolism in type II diabetes mellitus. Am. J. Med. 75:1989;273-277.
57. Canfield W.K., Hambidge K.M., Johnson L.K. Zinc nutriture in type I diabetes mellitus: relationship to growth measures and metabolic control. J. Pediatr. Gastroenterol. Nutr. 8:1984;577-584.
58. Melchior T., Simonsen K.W., Johannessen A.C., Binder C. Plasma zinc concentrations during the first 2 years after diagnosis of insulin-dependent diabetes mellitus: a prospective study. J. Intern. Med. 226:1989;53-58.
59. Strong S., Raskin P. Glycemic control and complications of diabetes: after diabetes control and complications trial. Diabetes Rev. 3:1995;237-257.
60. Furth A.J. Glycated proteins in diabetes. Br. J. Biomed. Sci. 54:1997;192-200.
61. Caballero F., Gerez E., Polo C.F., Vazquez E., Batlle A. Reducing sugars trigger delta aminolevulinate dehydratase inactivation: Evidence of in vitro Aspirin prevention. Gen. Pharmacol. 31:1998;441-445.